| Article Access Statistics|
| Viewed||1212 |
| Printed||15 |
| Emailed||0 |
| PDF Downloaded||31 |
| Comments ||[Add] |
| Cited by others ||1 |
Click on image for details.
|LETTER TO EDITOR
|Year : 2016 | Volume
| Issue : 6 | Page : 1310-1312
Wolfram (DIDMOAD) syndrome with ventral central pontine hyperintensity without brainstem atrophy
Kamble J Harsha1, K Parameswaran2
1 Department of Neuroimaging and Endovascular Neurosurgery, Indo-American Hospital, Brain and Spine Centre, Vaikom, Kerala, India
2 Department of Neurology, Indo-American Hospital, Brain and Spine Centre, Vaikom, Kerala, India
|Date of Web Publication||11-Nov-2016|
Kamble J Harsha
Department of Neuroimaging and Endovascular Neurosurgery, Indo-American Hospital, Brain and Spine Centre, Vaikom, Kerala
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Harsha KJ, Parameswaran K. Wolfram (DIDMOAD) syndrome with ventral central pontine hyperintensity without brainstem atrophy. Neurol India 2016;64:1310-2
A 27-year-old male, diagnosed to be having a juvenile-onset diabetes mellitus and bilateral sensory neural hearing loss, presented with an 8-year history of gradually progressive visual loss. The history was suggestive of the typical Wolfram (DIDMOAD, Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness) syndrome. He had features of hypogonadism, and no other neurological symptoms or signs were noted. His best corrected visual acuity was 3/60 N36 in the right eye and 6/60 N18 in the left eye. Fundus examination showed temporal disc pallor with moderate non-proliferative diabetic retinopathic changes in both eyes. Visual evoked potential (VEP) was not elicitable in both the eyes. His visual field charting revealed severe visual field defects with macular sparing [Figure 1]. He underwent a magnetic resonance imaging (MRI), which showed T2/fluid-attenuated inversion recovery (FLAIR) hyperintensity in the anterior half of lower pons [Figure 2]a-c. High signal intensity was seen in the ventral and central pons, with subtle hyperintensity in the ventral paramedian position [Figure 2]b and [Figure 2]c. No atrophy of the pons, cerebellum, or cerebellar peduncles was seen. Although subtle FLAIR hyperintensity was seen in the optic radiation, it was not entirely convincing [Figure 2]d. The posterior pituitary T1 hyperintense bright spot was seen, albeit small in size[Figure 2]e. Bilateral optic nerves were small with prominence of perioptic cerebrospinal fluid spaces[Figure 2]f-h. Mild T1 hyperintensity was seen in both the globus pallidi.
|Figure 1: Visual field chart showing macular sparing visual field defect in both eyes|
Click here to view
|Figure 2: (a) Midsagittal T2-weighted, (b) axial T2, (c) axial FLAIR MR images showing ventral lower pontine hyperintensity without volume loss, with normal cerebellum. (d) Axial FLAIR image showing normal optic radiation. (e) Midsagittal T1-weighted image showing small posterior pituitary bright spot. (f-h) Coronal and axial T2-weighted images showing bilateral optic nerve atrophy|
Click here to view
Wolfram syndrome 1 (WFS1) is a rare autosomal recessive genetic disorder, in which optic atrophy, diabetes mellitus, and hearing loss are associated with diabetes insipidus, commonly due to the mutation of the WFS1 gene on chromosome 4p16.1. Wolfram syndrome 2, in which optic atrophy, diabetes mellitus, and hearing loss are seen, but not diabetes insipidus, is caused by CISD2 gene mutation. Juvenile-onset diabetes mellitus and optic atrophy are minimal requirements for the diagnosis of both the varieties of WS, whereas sensorineural hearing loss, ataxia, and urinary tract problems are the other major symptoms, with or without diabetes insipidus. Juvenile diabetes mellitus is probably the first clinical manifestation of the syndrome, whereas visual deterioration and hearing loss present during the second or third decade of life. Ataxia or imbalance is one of the common neurological problems seen in up to 60% of patients; psychiatric symptoms , and cognitive impairment are the other less common neurological presentations.
MRI findings previously described in this syndrome are brainstem atrophy, optic tract atrophy, absent posterior pituitary T1 bright spot, cerebellar atrophy, and third ventricular atrophy. Although optic tract atrophy was reported in 100% of cases in larger series, in our case, there was no evidence of optic tract atrophy; however, the visual evoked potential (VEP) was inelicitable. This was attributed to sparing of some proportion of optic tract fibres sufficient enough to preserve his macular vision and give a normal MRI appearance but inadequate to give a positive response on VEP testing. Mild T1 hyperintensities in bilateral globus pallidi were probably suggestive of a more widespread degenerative process even in the absence of gross cerebral parenchymal atrophy. This finding is in accordance with a previous study, in which multimodal imaging demonstrated brain abnormalities even in the early stage of the syndrome. Previously reported cases showed either normal or absent posterior pituitary signal intensity on T1 weighted images; however, in our case, the posterior pituitary T1 bright spot was small but discernable. Due to progressive degeneration of supraoptic and paravertentricular nuclei, posterior pituitary atrophy may occur. This may lead to the absence of the posterior pituitary bright spot in the late stages, as well as its its presence in the early stages of the disease. Probably, our case is representative of an intermediate stage of degeneration in the spectrum. Moderate atrophy of the brainstem and cerebellum was described as the first sign even in patients without clinical evidence of neurological problems; however, the first sign in our case was T2/FLAIR hyperintensity in the central and ventral pons without atrophy. The possible etiology of this hyperintensity is the degeneration of the ventral nucleus of trapezoid body, that represents the major decussation of the central auditory pathway. As the patient had residual hearing for low frequencies, he did not have the advanced stage of the disease. Probably, only patients in an advanced stage produce the typical central and bilateral paramedian T2/FLAIR hyperintensities of ventral lower pons with associated atrophy.
In conclusion, we report a case of WS with T2/FLAIR hyperintensity in the ventral midline pons in the absence of brain atrophy. The presence of T2/FLAIR hyperintensity in anterior central pons could be one of the initial MRI abnormalities of the brain. In addition, our case describes the additional MRI findings associated with the syndrome, that is, bilateral globus pallidi T1 hyperintensities, and a small posterior pituitary T1 bright spot.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| » References|| |
Rigoli L, Di Bella C. Wolfram syndrome1 and Wolfram syndrome2. Curr Opin Pediatr2012;24:512-7.
Urano F. Wolfram Syndrome: Diagnosis, management, and treatment. Curr Diab Rep 2016;16:6.
Swift RG, Sadler DB, Swift M. Psychiatric findings in Wolfram syndrome homozygotes. Lancet 1990;336:667-9.
Swift RG, Perkins DO, Chase CL, Sadler DB, Swift M. Psychiatric disorders in 36 families with Wolfram syndrome. Am J Psychiatry 1991;148: 775-9.
Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-63.
Medlej R, Wasson J, Baz P, Azar S, Salti I, Loiselet J, et al
. Diabetes mellitus and optic atrophy: A study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab2004;89:1656-61.
Hershey T, Lugar HM, Shimony JS, Rutlin J, Koller JM, Perantie DC, et al
. Early brain vulnerability in Wolfram syndrome. PLoS One 2012;7:e40604.
Gocmen R, Guler E. Teaching NeuroImages: MRI of brain findings of Wolfram (DIDMOAD) syndrome. Neurology 2014;83:e213-4.
[Figure 1], [Figure 2]
|This article has been cited by|
||Commentary: Wolfram (DIDMOAD) syndrome: A progressive disorder with nonsynchronized clinical and imaging features
| ||GuruDutta Satyarthee |
| ||Neurology India. 2016; 64(6): 1312 |
|[Pubmed] | [DOI]|